Navigation Links
Roche Plans to Complete Ventana Offer on February 7th
Date:1/31/2008

BASEL, Switzerland, Jan. 31 /PRNewswire-FirstCall/ -- Roche (SWX: ROG.VX; RO.S; OTCQX; RHHBY) announced today that based on its review to date of known applicable antitrust laws, it is not aware of any such law that would prohibit its acceptance for payment of shares tendered pursuant to its outstanding Offer to Purchase shares of Ventana Medical Systems, Inc. (Nasdaq: VMSI). Accordingly, subject to satisfaction or waiver of the other conditions of the Offer, Roche intends to accept for payment Ventana shares tendered pursuant to the Offer at the scheduled expiration (7:00 p.m. EST on February 7, 2008), and to commence payment for those shares promptly.

Greenhill & Co. and Citi acted as financial advisors to Roche and Davis Polk & Wardwell acted as legal counsel.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the Pharmaceuticals Division totaled CHF 33.3 billion, and the Diagnostics Division posted sales of CHF 8.7 billion. Roche employs roughly 75,000 people worldwide and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA Approves New Roche West Nile Virus Blood Screening Test
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
6. MacroChem Announces Preferred Stock Conversions and $3.5 Million Private Placement
7. Nations Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract
8. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
9. Roche Extends Tender Offer for Ventana
10. Roche Offers Innovative Website Designed to Empower Cancer Patients
11. Neurochem reports results for third quarter of fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the ... and ADVOCATE is leading the transition. ADVOCATE, the only 100% radiology, revenue cycle ... 10 Tips for ICD-10. The ten tips are timely and relevant guidelines to ...
(Date:7/6/2015)... Irvine, CA (PRWEB) , ... July 06, 2015 ... ... for disease prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care ... disease, cancer, stroke and other serious medical conditions. Screenings are affordable and accurate ...
(Date:7/6/2015)... ... ... Seedstock today announced Pierre Sleiman, founder and CEO of Go Green ... Conference – “Innovation and the Small Farmer” – to be held Nov. 3-4 San ... will explore solutions and methodologies that small farmers and entrepreneurs are developing to improve ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... & Associates has once again teamed up with Family Emergency Shelter Coalition (FESCO) ... move toward self-sufficiency. FESCO was created especially to provide emergency services and support ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a bone ... risk of having a fracture through the bone health screenings conducted by American Bone ... are participating because our residents need this information to remain independent and strong for ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2
... ... The US Whey Proteins market is anticipated to reach 472.3 million pounds by 2015, driven ... technology of whey processing and investments in R&D are other major driving forces for the ... ...
... 1, 2010 - Shionogi Pharma, Inc., a U.S.-based group ... summarizing the results of two pivotal studies of the ... being developed for the treatment of primary premature ejaculation ... Urological Association (AUA) Annual Meeting in San Francisco. ...
... or too much/too little of the active ingredient , ... market them, men continue to buy them and experts ... for erectile dysfunction. , A new study, conducted in ... American Urological Association annual meeting in San Francisco, finds ...
... more females than males, organizers say , MONDAY, ... rates for women are generally on the downswing, ... rising, the American Lung Association (ALA) says. , ... from tobacco-related illness, the ALA estimates. And chronic ...
... ... Day. According to the World Health Organization, 1 billion people will die from ... given away to inform people about the significant adverse effect tobacco continues to ... No Tobacco Day on May 31. Download the e-book and access tools to ...
... caution , SUNDAY, May 30 (HealthDay News) -- New research ... bladder cancer and might even raise the risk of another ... researchers analyzed more than 10,000 questionnaires that men filled out ... than 60 percent of the men said they took supplements, ...
Cached Medicine News:Health News:US Whey Proteins Market to Reach 472.3 Million Pounds by 2015, According to New Report by Global Industry Analysts, Inc. 2Health News:US Whey Proteins Market to Reach 472.3 Million Pounds by 2015, According to New Report by Global Industry Analysts, Inc. 3Health News:Pivotal data for the investigational treatment PSD502 for primary premature ejaculation 2Health News:Pivotal data for the investigational treatment PSD502 for primary premature ejaculation 3Health News:Dangers Lurk in Impotence Drugs Sold on Web 2Health News:Women Smokers Targeted on 'World No Tobacco Day' 2Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 2Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 3Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 4Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 5Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 6Health News:Vitamins Fail to Protect Men Against Bladder Cancer 2
(Date:7/6/2015)... and FARMINGTON, Conn. ... (NYSE MKT: PTN), a biopharmaceutical company developing targeted, ... with significant unmet medical need and commercial potential, ... private placement of Series E warrants to purchase ... F warrants to purchase 2,191,781 shares of its ...
(Date:7/6/2015)... , July 6, 2015   Cepheid (Nasdaq: ... financial results for its 2015 second quarter ended June ... close of the market. The Company will ... on Thursday, July 23, 2015, to discuss the results.  ... at http://ir.cepheid.com at least 15 minutes before ...
(Date:7/6/2015)... , July 6, 2015 /PRNewswire/ -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced that its board of directors ... 6, 2015, from Simin Zhang , chairman of ... Neptunus Drugstore Holding Ltd., an investment vehicle wholly owned ...
Breaking Medicine Technology:Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6
...  In her advocacy for effective disease prevention and health ... joined the Southeast Michigan Beacon Community (SEMBC) today to ... a kickoff event, attended by over 225 guests, at ... brought together state and local governments, health care systems, ...
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... ASPIRE trial, a Phase 3 international clinical trial evaluating ... dexamethasone in patients with relapsed multiple myeloma.  The company ... Administration (FDA) for a Special Protocol Assessment (SPA) and ...
Cached Medicine Technology:U.S. Surgeon General Supports Detroit in Fight Against Diabetes 2U.S. Surgeon General Supports Detroit in Fight Against Diabetes 3U.S. Surgeon General Supports Detroit in Fight Against Diabetes 4Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 2Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 3Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 4Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma 5
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
Medicine Products: